Citable filing context
MKC's research view summarizes recent SEC filing context, starting with earnings from Oct 1, 2026.
| Filed | Item | Context |
|---|---|---|
| Oct 1, 2026 | earnings | McCormick reported Q3 2026 net sales growth of 17.4% and adjusted EPS of $0.86, reaffirming its 2026 outlook. |
| Sep 28, 2026 | other | McCormick & Company dismissed Ernst & Young as its independent auditor and engaged KPMG for fiscal year 2027. |
| Aug 28, 2026 | management_change | Anne Bramman announced her resignation from McCormick's board, and Valarie Sheppard will become Audit Committee Chair. |
| Oct 1, 2026 | Guidance: adjusted_eps | 3.05 to 3.13 |
| Oct 1, 2026 | Guidance: adjusted_operating_income_growth | 16.00 to 20.00 |
| Oct 1, 2026 | Guidance: net_sales_growth | 13.00 to 17.00 |
| Oct 1, 2026 | mda_quarterly | McCormick & Company achieved Q3 2026 net sales growth of 17.4% to $2.02 billion (1.9% organic). Growth was propelled by a 14.6% contribution from acquiring a 75% controlling interest in McCormick de Mexico for $750 million and 2.2% in pricing gains, offsetting a 0.3% volume/mix decline. Consumer segment sales surged 24.9% (1.1% organic), while Flavor Solutions rose 7.7% (3.0% organic), driven by expansion in China and the broader APAC region. Gross margin expanded 190 basis points to 39.3%, benefited by the Mexico acquisition, pricing, and Comprehensive Continuous Improvement cost savings, despite pressure from rising commodity costs and Middle East conflict-driven freight inflation. Q3 reported operating income declined 24.8% to $217.0 million due to $141.5 million in special charges—mainly long-lived asset impairments and transaction costs related to the pending Reverse Morris Trust merger with Unilever Foods. Adjusted operating income grew 22.1% to $358.5 million, with adjusted diluted EPS at $0.86. The pending Unilever Foods transaction includes a $15.7 billion cash payment supported by committed bridge and term loan facilities. For fiscal 2026, McCormick projects net sales to grow 13% to 17% (1% to 3% organic) and adjusted diluted EPS of $3.05 to $3.13. |
| Jun 25, 2026 | mda_quarterly | McCormick & Company reported second-quarter 2026 net sales growth of 16.7%, driven primarily by the $750 million acquisition of a controlling interest in McCormick de Mexico and favorable pricing. Organic net sales grew 1.7%, with the Flavor Solutions segment outperforming the Consumer segment in organic growth (2.9% versus 0.8%). Gross profit margins expanded by 270 basis points, supported by the IEEPA tariff refund and the Comprehensive Continuous Improvement (CCI) program, though partially offset by increased commodity costs and Middle East conflict-related freight expenses. A pivotal strategic development is the pending Reverse Morris Trust merger with Unilever Foods, which includes a $15.7 billion cash payment to Unilever. For fiscal 2026, the company projects net sales growth between 13% and 17% and adjusted diluted EPS between $3.05 and $3.13. Management expects to increase brand marketing investments by low to mid-teens digits to sustain volume trends. Key financial risks include volatility in raw materials—specifically dairy, pepper, onion, and garlic—and ongoing geopolitical instability. Liquidity remains sufficient to fund the Unilever transaction through a combination of bridge and term loan facilities, alongside existing revolving credit. |
Source: SEC EDGAR filing text and events; period Oct 1, 2026; filed Oct 1, 2026.
MKC company research is free during early access. All you need is an account, with no card required. The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay open without one.
Continue research
Follow same-sector companies and source explainers connected to the research view.
A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.